Related references
Note: Only part of the references are listed.Structural Basis of 2-Phenylamino-4-phenoxyquinoline Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Arthit Makarasen et al.
MOLECULES (2022)
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
Rana Abdelnabi et al.
NATURE COMMUNICATIONS (2022)
Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease -in silicoapproach
Vankudavath Raju Naik et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - anin silicodocking and molecular dynamics simulation study
Rajesh Ghosh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases
Chun-Chi Chen et al.
FEBS JOURNAL (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
An update review of emerging small-molecule therapeutic options for COVID-19
Dengke Tian et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations
Bilal Ahmad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
Matteo Pavan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity
Kemel Arafet et al.
CHEMICAL SCIENCE (2021)
Cross-species transmission of the newly identified coronavirus 2019-nCoV
Wei Ji et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Binding interaction of potent HIV-1 NNRTIs, amino-oxy-diarylquinoline with the transport protein using spectroscopic and molecular docking
Suwicha Patnin et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
Daniel W. Kneller et al.
NATURE COMMUNICATIONS (2020)
Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
C-H center dot center dot center dot S interaction exhibits all the characteristics of conventional hydrogen bonds
Sanat Ghosh et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2020)
Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach
Junwei Zhou et al.
FASEB JOURNAL (2019)
Molecular Docking Studies and Synthesis of Amino-oxy-diarylquinoline Derivatives as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
Arthit Makarasen et al.
DRUG RESEARCH (2019)
Inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants: Insights from molecular docking and ONIOM calculations
Pabitra Narayan Samanta et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: an evidence obtained from ONIOM method
Pornthip Boonsri et al.
MEDCHEMCOMM (2011)
Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
Shu-Chun Cheng et al.
BIOPHYSICAL JOURNAL (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design
Xiaoyu Xue et al.
JOURNAL OF VIROLOGY (2008)
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
